Related Attributes
Product details
Fevipiprant powder, also known as NVP-QAW039 or QAW039, is an orally active and potent CRTh2 receptor antagonist with potential use in asthma treatment. Fevipiprant CAS 872365-14-5 reduces eosinophilic airway inflammation and is well tolerated in patients with persistent moderate to severe asthma who have elevated eosinophilic counts in the sputum despite inhaled corticosteroid treatment. Fevipiprant Raw Materials have good safety.
Applications/Functions of Fevipiprant powder
Fevipiprant powder is used orally to treat asthma and has been successfully targeted for severe eosinophilic asthma.
Physicochemical Property of Fevipiprant powder
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2023 Xi'an Henrikang Biotech Co., Ltd.,